Agilon Health Is Maintained at In-Line by Evercore ISI Group
Evercore Maintains Agilon Health(AGL.US) With Hold Rating, Cuts Target Price to $4
BofA Securities Downgrades Agilon Health(AGL.US) to Sell Rating, Announces Target Price $3
Agilon Health Price Target Announced at $3.00/Share by B of A Securities
Agilon Health Analyst Ratings
Agilon Health Downgraded to Underperform From Buy at BofA
Jefferies Maintains Agilon Health(AGL.US) With Hold Rating, Cuts Target Price to $4.75
Maintaining Equilibrium: Hold Rating on Agilon Health Amidst Growth and Risk
Analysts Offer Insights on Healthcare Companies: Agilon Health (AGL) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)
Agilon Health Analyst Ratings
Agilon Health Holds Steady: A Balanced Analysis of Performance and Uncertainties
Agilon Health Analyst Ratings
Agilon Health Price Target Maintained With a $8.00/Share by RBC Capital
Agilon Health Analyst Ratings
Truist Financial Sticks to Its Hold Rating for Agilon Health (AGL)
Agilon Health (AGL) Gets a Hold From Evercore ISI
RBC Capital Reaffirms Their Buy Rating on Agilon Health (AGL)
Maintaining Buy Rating on Agilon Health Amidst Strategic Growth and Financial Resilience
TD Cowen Reaffirms Their Hold Rating on Agilon Health (AGL)
Agilon Health Analyst Ratings